Global Health Ltd Amends Appendix 4C for Dec 2025 Quarter
Key points
- Group cashflow of ($346K) for the six months to Dec-25 was 18% above the group cashflow of ($292K) in the six months to Dec-24
- Increase in cash outflows included one-off staff exit costs and acquisition of multiple AI enterprise platforms
- Correction to previous statement that cashflow was 16% better
Full summary
Global Health Limited (ASX: GLH) has released an amendment to its Appendix 4C Cash Flow Report for the quarter ended 31st December 2025. The company previously stated that the group cashflow of ($986K) for the six months to December-25 was 16% better than the group cashflow of ($1,170K) in the six months to December-24. However, the correct statement is that the group cashflow of ($346K) for the six months to December-25 was 18% above the group cashflow of ($292K) in the six months to December-24. The increase in cash outflows over the half-year to December 2025 included one-off staff exit costs and the acquisition of multiple AI enterprise platforms used across all departments.
Summary generated by a large language model. Please interpret with care.